Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes
Crossref DOI link: https://doi.org/10.1007/s00125-016-4146-6
Published Online: 2016-11-21
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Funding for this research was provided by:
University of Sheffield
License valid from 2016-11-21